Summary
SymBio Pharmaceuticals Limited (SymBio) is a biopharmaceutical company that conducts research and development, and manufactures new drug candidates. The company develops drug delivery products such as transdermal patch containing granisetron for the treatment of chemotherapy induced nausea or vomiting. It offers products for use in the therapeutic areas of autoimmune, oncology and hematology diseases. SymBio offers packaging, labeling and storage services. The company offers designing and operation of clinical tests. It manufactures and markets its drugs with the help of domestic and foreign pharmaceutical companies. SymBio is headquartered in Minato-ku, Japan.
SymBio Pharmaceuticals Limited (4582) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
SymBio Pharma Secures US$24.5 Million In Series E Financing Round 10
SymBio Pharma Secures US$8 Million In Second Tranche Of Series D Financing 12
Licensing Agreements 13
SymBio Pharma Enters into Licensing Agreement with The Medicines Company 13
Onconova Therapeutics Amends its Licensing Agreement with SymBio Pharma for Rigosertib 14
SymBio Pharma Enters Into Licensing Agreement With Cephalon 15
Equity Offering 16
SymBio Pharma Completes IPO Of Common Stock For US$37.1 Million 16
Debt Offering 18
Symbio Pharma Completes Private Placement Of Bonds Due 2016 For US$12 Million 18
SymBio Pharmaceuticals Limited - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Key Facts, 2015 1
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
SymBio Pharmaceuticals Limited, Deals By Therapy Area, 2010 to YTD 2016 8
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
SymBio Pharma Secures US$24.5 Million In Series E Financing Round 10
SymBio Pharma Secures US$8 Million In Second Tranche Of Series D Financing 12
SymBio Pharma Enters into Licensing Agreement with The Medicines Company 13
Onconova Therapeutics Amends its Licensing Agreement with SymBio Pharma for Rigosertib 14
SymBio Pharma Enters Into Licensing Agreement With Cephalon 15
SymBio Pharma Completes IPO Of Common Stock For US$37.1 Million 16
Symbio Pharma Completes Private Placement Of Bonds Due 2016 For US$12 Million 18
SymBio Pharmaceuticals Limited, Key Competitors 19
SymBio Pharmaceuticals Limited, Key Employees 20
List of Figures
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
SymBio Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8